Rocket Lab reported third-quarter earnings that beat expectations and showed a backlog increase of over 50% compared to the previous quarter. Despite these positive financial results, the company's stock fell about 16% year to date through Monday trading. The drop suggests investor concerns remain despite the strong backlog growth, possibly due to broader market conditions or future outlook uncertainties. Investors will be watching upcoming developments and guidance for further clarity on Rocket Lab's performance.
As of Nov 10, 2026 04:11 WIB, Rocket Lab (RKLB) shares are trading at USD 55.25 on Pluang, showing a 1-day gain of 4.11%. Despite the recent stock decline year to date, the platform data reveals a market cap of $33.93 billion and a high sell order activity at 79%. The typical hold time for RKLB on Pluang is 34 days, indicating moderate investor engagement.
Rocket Lab announced over $515 million in Neutron launch contracts during Q3 2026, securing eight missions from five constellation operators. The demand has pushed the Neutron backlog to 16 missions, with launch prices rising from $55 million to $70 ...
Rocket Lab reported a record $268 million in revenue for Q3 2026, a 73% year-on-year increase, alongside a backlog growth to $3.57 billion, up 52% sequentially. The company secured nearly $1 billion in new launch contracts in the quarter, including $...
SpaceX's stock fell nearly 20% in the past month due to a Democratic sweep in Texas, raising concerns about regulatory hurdles for its AI and data center expansion. Despite this, analysts remain bullish, with an average price target suggesting 91% up...
SpaceX shares climbed 4% to $128.92 as tech stocks recovered after a post-election selloff that had pushed SpaceX down 25% in a month. The rebound is supported by strong U.S. jobs data and a rotation back into growth stocks, though challenges remain ...
Rocket Lab's stock has fallen nearly 65% since May, driven by high initial expectations and a cooling interest in space stocks. The company's Neutron rocket delay to 2027 and its $8 billion acquisition of Iridium introduce significant risks, includin...
